Abstract
DNA methylation is a key epigenetic modification involved in gene regulation whose contribution to disease susceptibility is still not fully understood. As the cost of genome sequencing technologies continues to drop, it will soon become commonplace to perform genome-wide quantification of DNA methylation at a single base-pair resolution. However, the demand for its accurate quantification might vary across studies. When the scope of the analysis is to detect regions of the genome with different methylation patterns between two or more conditions, e.g., case vs control; treatments vs placebo, accuracy is not crucial. This is the case in epigenome-wide association studies used as genome-wide screening of methylation changes to detect new candidate genes and regions associated with a specific disease or condition. If the aim of the analysis is to use DNA methylation measurements as a biomarker for diseases diagnosis and treatment (Laird, Nat Rev Cancer 3:253–266, 2003; Bock, Epigenomics 1:99–110, 2009), it is instead recommended to produce accurate methylation measurements. Furthermore, if the objective is the detection of DNA methylation in subclonal tumor cell populations or in circulating tumor DNA or in any case of mosaicism, the importance of accuracy becomes critical. The aim of this chapter is to describe the factors that could affect the precise measurement of methylation levels and a recent Bayesian statistical method called MethylCal and its extension that have been proposed to minimize this problem.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3:253–266. https://doi.org/10.1038/nrc1045
Bock C (2009) Epigenetic biomarker development. Epigenomics 1:99–110. https://doi.org/10.2217/epi.09.6
Shapiro R, Weisgras JM (1970) Bisulfite-catalyzed transamination of cytosine and cytidine. Biochem Biophys Res Commun 40:839–843. https://doi.org/10.1016/0006-291X(70)90979-4
Hayatsu H, Wataya Y, Kai K (1970) The addition of sodium bisulfite to uracil and to cytosine. J Am Chem Soc 92:724–726. https://doi.org/10.1021/ja00706a062
Wang RYH, Gehrke CW, Ehrlich M (1980) Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids Res 8:4777–4790. https://doi.org/10.1093/nar/8.20.4777
Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89:1827–1831. https://doi.org/10.1073/pnas.89.5.1827
Yu H, Hahn Y, Yang I (2015) Reference materials for calibration of analytical biases in quantification of DNA methylation. PLoS One 10:8–19. https://doi.org/10.1371/journal.pone.0137006
Masser DR, Berg AS, Freeman WM (2013) Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next-generation sequencing. Epigenetics Chromatin 6:1. https://doi.org/10.1186/1756-8935-6-33
Warnecke PM, Stirzaker C, Melki JR, Millar DS, Paul CL, Clark SJ (1997) Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 25:4422–4426. https://doi.org/10.1093/nar/25.21.4422
Wojdacz TK, Borgbo T, Hansen LL (2009) Primer design versus PCR bias in methylation independent PCR amplifications. Epigenetics 4:231–234. https://doi.org/10.4161/epi.9020
Wojdacz TK, Hansen LL, Dobrovic A (2008) A new approach to primer design for the control of PCR bias in methylation studies. BMC Res Notes 1:3–5. https://doi.org/10.1186/1756-0500-1-54
Moskalev EA, Zavgorodnij MG, Majorova SP, Vorobjev IA, Jandaghi P, Bure IV, Hoheisel JD (2011) Correction of PCR-bias in quantitative DNA methylation studies by means of cubic polynomial regression. Nucleic Acids Res 39. https://doi.org/10.1093/nar/gkr213
Ochoa E, Zuber V, Fernandez-Jimenez N, Bilbao JR, Clark GR, Maher ER, Bottolo L (2019) MethylCal: Bayesian calibration of methylation levels. Nucleic Acids Res 47:e81. https://doi.org/10.1093/nar/gkz325
Rother KI, Silke J, Georgiev O, Schaffner W, Matsuo K (1995) Influence of DNA sequence and methylation status on bisulfite conversion of cytosine residues. Anal Biochem 231:263–265. https://doi.org/10.1006/abio.1995.1530
Zhao J, Bacolla A, Wang G, Vasquez KM (2010) Non-B DNA structure-induced genetic instability and evolution. Cell Mol Life Sci 67:43–62. https://doi.org/10.1007/s00018-009-0131-2
Clark J, Smith SS (2008) Secondary structure at a hot spot for DNA methylation in DNA from human breast cancers. Cancer Genomics Proteomics 5:241–252
Bacolla A, Cooper DN, Vasquez KM, Tainer JA (2018) Non-B DNA structure and mutations causing human genetic disease. In: eLS. Wiley, pp 1–15
Bacolla A, Wells RD (2009) Non-B DNA conformations as determinants of mutagenesis and human disease. Mol Carcinog 48:273–285. https://doi.org/10.1002/mc.20507
Walter J, Hutter B, Khare T, Paulsen M (2006) Repetitive elements in imprinted genes. Cytogenet Genome Res 113:109–115. https://doi.org/10.1159/000090821
Ziller MJ, Gu H, Müller F, Donaghey J, Tsai LTY, Kohlbacher O, De Jager PL, Rosen ED, Bennett DA, Bernstein BE, Gnirke A, Meissner A (2013) Charting a dynamic DNA methylation landscape of the human genome. Nature 500:477–481. https://doi.org/10.1038/nature12433
Zhou L, Ng HK, Drautz-Moses DI, Schuster SC, Beck S, Kim C, Chambers JC, Loh M (2019) Systematic evaluation of library preparation methods and sequencing platforms for high-throughput whole genome bisulfite sequencing. Sci Rep 9:1–16. https://doi.org/10.1038/s41598-019-46875-5
Ziller MJ, Hansen KD, Meissner A, Aryee MJ (2015) Coverage recommendations for methylation analysis by whole-genome bisulfite sequencing. Nat Methods 12:230–232. https://doi.org/10.1038/nmeth.3152
Zhang W, Spector TD, Deloukas P, Bell JT, Engelhardt BE (2015) Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements. Genome Biol 16. https://doi.org/10.1186/s13059-015-0581-9
(2006) Linear mixed-effects models: basic concepts and examples. In: Mixed-effects models in S and S-PLUS. Springer-Verlag, pp 3–56
Rue H, Martino S, Chopin N (2009) Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Ser B Stat Methodol 71:319–392. https://doi.org/10.1111/j.1467-9868.2008.00700.x
Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A (2002) Bayesian measures of model complexity and fit. J R Stat Soc Ser B Stat Methodol 64:583–616. https://doi.org/10.1111/1467-9868.00353
Monk D, Mackay DJG, Eggermann T, Maher ER, Riccio A (2019) Genomic imprinting disorders: lessons on how genome, epigenome and environment interact. Nat Rev Genet 20:235–248. https://doi.org/10.1038/s41576-018-0092-0
Claus R, Lucas DM, Ruppert AS, Williams KE, Weng D, Patterson K, Zucknick M, Oakes CC, Rassenti LZ, Greaves AW, Geyer S, Wierda WG, Brown JR, Gribben JG, Barrientos JC, Rai KR, Kay NE, Kipps TJ, Shields P, Zhao W, Grever MR, Plass C, Byrd JC (2014) Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. Blood 124:42–48. https://doi.org/10.1182/blood-2014-02-555722
DeVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C, Habermann JK, Fleshner PR, Oubre BM, Day R, Sledziewski AZ, Lofton-Day C (2009) Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 55:1337–1346. https://doi.org/10.1373/clinchem.2008.115808
Giovannetti E, Codacci-Pisanelli G, Peters GJ (2012) TFAP2E-DKK4 and chemoresistance in colorectal cancer. N Engl J Med 366:966. https://doi.org/10.1056/NEJMc1201170
Hegi ME, Diserens AC, Gorlia T, Hamou MF, De Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JEC, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003. https://doi.org/10.1056/NEJMoa043331
Queirós AC, Villamor N, Clot G, Martinez-Trillos A, Kulis M, Navarro A, Penas EMM, Jayne S, Majid A, Richter J, Bergmann AK, Kolarova J, Royo C, Russiñol N, Castellano G, Pinyol M, Bea S, Salaverria I, López-Guerra M, Colomer D, Aymerich M, Rozman M, Delgado J, Giné E, González-Díaz M, Puente XS, Siebert R, Dyer MJS, López-Otín C, Rozman C, Campo E, López-Guillermo A, Martín-Subero JI (2015) A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact. Leukemia 29:598–605. https://doi.org/10.1038/leu.2014.252
Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC (2011) Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 17:510–513. https://doi.org/10.1038/nm.2312
McDermott E, Ryan EJ, Tosetto M, Gibson D, Burrage J, Keegan D, Byrne K, Crowe E, Sexton G, Malone K, Harris RA, Kellermayer R, Mill J, Cullen G, Doherty GA, Mulcahy H, Murphy TM (2016) DNA methylation profiling in inflammatory bowel disease provides new insights into disease pathogenesis. J Crohns Colitis 10:77–86. https://doi.org/10.1093/ecco-jcc/jjv176
Imgenberg-Kreuz J, Almlöf JC, Leonard D, Sjöwall C, Syvänen AC, Rönnblom L, Sandling JK, Nordmark G (2019) Shared and unique patterns of DNA methylation in systemic lupus erythematosus and primary Sjögren’s syndrome. Front Immunol 10:1686. https://doi.org/10.3389/fimmu.2019.01686
Fernandez-Jimenez N, Garcia-Etxebarria K, Plaza-Izurieta L, Romero-Garmendia I, Jauregi-Miguel A, Legarda M, Ecsedi S, Castellanos-Rubio A, Cahais V, Cuenin C, Degli Esposti D, Irastorza I, Hernandez-Vargas H, Herceg Z, Bilbao JR (2019) The methylome of the celiac intestinal epithelium harbours genotype-independent alterations in the HLA region. Sci Rep 9:1–13. https://doi.org/10.1038/s41598-018-37746-6
Maher ER, Reik W (2000) Beckwith-Wiedemann syndrome: imprinting in clusters revisited. J Clin Invest 105:247–252
Lea AJ, Tung J, Zhou X (2015) A flexible, efficient binomial mixed model for identifying differential DNA methylation in bisulfite sequencing data. PLoS Genet 11(11):e1005650. https://doi.org/10.1371/journal.pgen.1005650
Jin Z, Liu Y (2018) DNA methylation in human diseases. Genes Dis 5:1–8. https://doi.org/10.1016/j.gendis.2018.01.002
Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A, Reinius L, Acevedo N, Taub M, Ronninger M, Shchetynsky K, Scheynius A, Kere J, Alfredsson L, Klareskog L, Ekström TJ, Feinberg AP (2013) Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 31:142–147. https://doi.org/10.1038/nbt.2487
Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aïssi D, Wahl S, Meduri E, Morange PE, Gagnon F, Grallert H, Waldenberger M, Peters A, Erdmann J, Hengstenberg C, Cambien F, Goodall AH, Ouwehand WH, Schunkert H, Thompson JR, Spector TD, Gieger C, Trégouët DA, Deloukas P, Samani NJ (2014) DNA methylation and body-mass index: a genome-wide analysis. Lancet 383:1990–1998. https://doi.org/10.1016/S0140-6736(13)62674-4
Andrews SV, Ellis SE, Bakulski KM, Sheppard B, Croen LA, Hertz-Picciotto I, Newschaffer CJ, Feinberg AP, Arking DE, Ladd-Acosta C, Fallin MD (2017) Cross-tissue integration of genetic and epigenetic data offers insight into autism spectrum disorder. Nat Commun 8:1–10. https://doi.org/10.1038/s41467-017-00868-y
Acknowledgments
Alan Turing Institute under the Engineering and Physical Sciences Research Council [EP/N510129/1 to L.B.]. The authors thank Jose Ramon Bilbao for providing the celiac data as well as Nora Fernandez-Jimenez and Eamonn Maher for useful discussion regarding the results of the celiac data and mosaic Beckwith–Wiedemann syndrome.
Conflict of Interest
The views expressed are those of the authors and not necessarily those of the NHS or Department of Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ochoa, E., Zuber, V., Bottolo, L. (2022). Accurate Measurement of DNA Methylation: Challenges and Bias Correction. In: Guan, W. (eds) Epigenome-Wide Association Studies. Methods in Molecular Biology, vol 2432. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1994-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1994-0_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1993-3
Online ISBN: 978-1-0716-1994-0
eBook Packages: Springer Protocols